Humana Inc (NYSE:HUM) SVP Jody L. Bilney sold 4,600 shares of the company’s stock in a transaction dated Friday, May 5th. The shares were sold at an average price of $230.16, for a total value of $1,058,736.00. Following the completion of the sale, the senior vice president now directly owns 8,978 shares of the company’s stock, valued at $2,066,376.48. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
Shares of Humana Inc (NYSE:HUM) traded down 0.40% during mid-day trading on Friday, hitting $227.89. The stock had a trading volume of 1,356,560 shares. The firm has a 50 day moving average price of $219.16 and a 200-day moving average price of $207.26. Humana Inc has a 12 month low of $150.00 and a 12 month high of $233.66. The stock has a market cap of $32.89 billion, a P/E ratio of 23.23 and a beta of 0.91.
Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, May 3rd. The insurance provider reported $2.75 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.55 by $0.20. Humana had a return on equity of 13.09% and a net margin of 1.09%. The business had revenue of $13.76 billion for the quarter, compared to the consensus estimate of $13.61 billion. During the same period in the previous year, the business earned $1.86 earnings per share. On average, equities research analysts forecast that Humana Inc will post $11.14 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 31st. Stockholders of record on Friday, June 30th will be given a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, June 28th. This represents a $1.60 annualized dividend and a dividend yield of 0.70%. Humana’s payout ratio is 29.59%.
ILLEGAL ACTIVITY WARNING: “Humana Inc (HUM) SVP Sells $1,058,736.00 in Stock” was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2017/05/19/humana-inc-hum-svp-jody-l-bilney-sells-4600-shares-updated.html.
Several institutional investors have recently made changes to their positions in HUM. Bank of Nova Scotia increased its position in shares of Humana by 4.6% in the first quarter. Bank of Nova Scotia now owns 3,478 shares of the insurance provider’s stock valued at $717,000 after buying an additional 152 shares during the last quarter. Financial Advisors Network Inc. boosted its stake in shares of Humana by 6.1% in the first quarter. Financial Advisors Network Inc. now owns 1,367 shares of the insurance provider’s stock valued at $316,000 after buying an additional 79 shares during the period. Point72 Asia Hong Kong Ltd purchased a new stake in shares of Humana during the first quarter valued at about $128,000. Point72 Asset Management L.P. boosted its stake in shares of Humana by 721.5% in the first quarter. Point72 Asset Management L.P. now owns 211,128 shares of the insurance provider’s stock valued at $43,522,000 after buying an additional 185,428 shares during the period. Finally, Janus Capital Management LLC boosted its stake in shares of Humana by 31.6% in the first quarter. Janus Capital Management LLC now owns 994,186 shares of the insurance provider’s stock valued at $204,936,000 after buying an additional 238,909 shares during the period. Institutional investors and hedge funds own 93.00% of the company’s stock.
A number of analysts recently issued reports on the company. Cowen and Company reissued an “outperform” rating and set a $230.00 target price on shares of Humana in a research note on Tuesday, April 25th. Jefferies Group LLC reaffirmed a “buy” rating and set a $237.00 price target on shares of Humana in a report on Friday, March 24th. Evercore ISI reaffirmed an “outperform” rating and set a $240.00 price target on shares of Humana in a report on Tuesday, April 25th. CIBC reaffirmed an “outperform” rating on shares of Humana in a report on Thursday, March 30th. Finally, Zacks Investment Research cut Humana from a “buy” rating to a “hold” rating in a research report on Monday, April 24th. Nine investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $216.12.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with MarketBeat.com's FREE daily email newsletter.